These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27681991)

  • 1. Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.
    Engelhardt EG; Pieterse AH; Han PK; van Duijn-Bakker N; Cluitmans F; Maartense E; Bos MM; Weijl NI; Punt CJ; Quarles van Ufford-Mannesse P; Sleeboom H; Portielje JE; van der Hoeven KJ; Woei-A-Jin FJ; Kroep JR; de Haes HC; Smets EM; Stiggelbout AM
    Med Decis Making; 2017 Apr; 37(3):179-192. PubMed ID: 27681991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making.
    Kunneman M; Engelhardt EG; Ten Hove FL; Marijnen CA; Portielje JE; Smets EM; de Haes HJ; Stiggelbout AM; Pieterse AH
    Acta Oncol; 2016; 55(2):134-9. PubMed ID: 26237738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communicating uncertainty in cancer prognosis: A review of web-based prognostic tools.
    Harrison M; Han PKJ; Rabin B; Bell M; Kay H; Spooner L; Peacock S; Bansback N
    Patient Educ Couns; 2019 May; 102(5):842-849. PubMed ID: 30579771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making.
    Engelhardt EG; Pieterse AH; van der Hout A; de Haes HJ; Kroep JR; Quarles van Ufford-Mannesse P; Portielje JE; Smets EM; Stiggelbout AM
    Eur J Cancer; 2016 Oct; 66():55-66. PubMed ID: 27525573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating Uncertainty in Benefits and Harms: A Review of Patient Decision Support Interventions.
    Bansback N; Bell M; Spooner L; Pompeo A; Han PKJ; Harrison M
    Patient; 2017 Jun; 10(3):311-319. PubMed ID: 27905072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probabilities of benefit and harms of preoperative radiotherapy for rectal cancer: What do radiation oncologists tell and what do patients understand?
    Kunneman M; Stiggelbout AM; Marijnen CA; Pieterse AH
    Patient Educ Couns; 2015 Sep; 98(9):1092-8. PubMed ID: 26025810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologists' Communication About Uncertain Information in Second Opinion Consultations: A Focused Qualitative Analysis.
    van Someren JL; Lehmann V; Stouthard JM; Stiggelbout AM; Smets EMA; Hillen MA
    Front Psychol; 2021; 12():635422. PubMed ID: 34135806
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
    Siminoff LA; Graham GC; Gordon NH
    Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suggestion for the quantification of precise and bounded probability to quantify epistemic uncertainty in scientific assessments.
    Raices Cruz I; Troffaes MCM; Sahlin U
    Risk Anal; 2022 Feb; 42(2):239-253. PubMed ID: 35007348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "This Is What We Don't Know": Treating Epistemic Uncertainty in Bayesian Networks for Risk Assessment.
    Sahlin U; Helle I; Perepolkin D
    Integr Environ Assess Manag; 2021 Jan; 17(1):221-232. PubMed ID: 33151017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Integration of Emotional, Physiologic, and Communication Responses to Medical Oncology Surveillance Appointments During Breast Cancer Survivorship.
    Clayton MF; Dingley C; Donaldson G
    Cancer Nurs; 2017; 40(2):124-134. PubMed ID: 27088607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.
    Belkora JK; Rugo HS; Moore DH; Hutton DW; Chen DF; Esserman LJ
    BMC Cancer; 2009 Apr; 9():127. PubMed ID: 19400938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Irrelevance of the Risk-Uncertainty Distinction.
    Roser D
    Sci Eng Ethics; 2017 Oct; 23(5):1387-1407. PubMed ID: 28597223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussing complementary therapy use with early-stage breast cancer patients: exploring the communication gap.
    Juraskova I; Hegedus L; Butow P; Smith A; Schofield P
    Integr Cancer Ther; 2010 Jun; 9(2):168-76. PubMed ID: 20462858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial.
    Hack TF; Pickles T; Bultz BD; Ruether JD; Weir LM; Degner LF; Mackey JR
    J Clin Oncol; 2003 Nov; 21(22):4138-44. PubMed ID: 14615442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?
    Lee KL; Janz NK; Zikmund-Fisher BJ; Jagsi R; Wallner LP; Kurian AW; Katz SJ; Abrahamse P; Hawley ST
    Med Decis Making; 2018 Jan; 38(1):95-106. PubMed ID: 28814131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facing epistemic and complex uncertainty in serious illness: The role of mindfulness and shared mind.
    Epstein RM
    Patient Educ Couns; 2021 Nov; 104(11):2635-2642. PubMed ID: 34334265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project.
    Visser LNC; Pelt SAR; Kunneman M; Bouwman FH; Claus JJ; Kalisvaart KJ; Hempenius L; de Beer MH; Roks G; Boelaarts L; Kleijer M; van der Flier WM; Smets EMA; Hillen MA
    Health Expect; 2020 Feb; 23(1):52-62. PubMed ID: 31638322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussing adjuvant cancer therapy.
    Leighl N; Gattellari M; Butow P; Brown R; Tattersall MH
    J Clin Oncol; 2001 Mar; 19(6):1768-78. PubMed ID: 11251008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How long do I have? Observational study on communication about life expectancy with advanced cancer patients.
    Henselmans I; Smets EMA; Han PKJ; de Haes HCJC; Laarhoven HWMV
    Patient Educ Couns; 2017 Oct; 100(10):1820-1827. PubMed ID: 28511804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.